Optimal thromboprophylaxis strategies in non-critically ill patients with COVID-19 pneumonia. The PROTHROMCOVID Randomized Controlled Trial
View ORCID ProfileNuria Muñoz-Rivas, Jesús Aibar, Cristina Gabara-Xancó, Ángela Trueba-Vicente, View ORCID ProfileAna Urbelz-Pérez, Vicente Gómez-Del Olmo, View ORCID ProfilePablo Demelo-Rodriguez, View ORCID ProfileAlberto Rivera-Gallego, View ORCID ProfilePau Bosch-Nicolau, View ORCID ProfileMontserrat Perez-Pinar, Mónica Rios-Prego, Olga Madridano-Cobo, Laura Ramos-Alonso, Jesús Alonso-Carrillo, Iria Francisco-Albelsa, View ORCID ProfileEdelmira Martí-Saez, Ana Maestre-Peiró, Manuel Méndez-Bailón, View ORCID ProfileJosé Ángel Hernández-Rivas, Juan Torres-Macho, The PROTHROMCOVID Trial investigators
doi: https://doi.org/10.1101/2022.05.03.22274594
Nuria Muñoz-Rivas
1Department of Internal Medicine. Hospital Universitario Infanta Leonor. Madrid. Spain
Jesús Aibar
2Department of Internal Medicine. Hospital Clínic. IDIBAPS, University of Barcelona, Barcelona. Spain
Cristina Gabara-Xancó
2Department of Internal Medicine. Hospital Clínic. IDIBAPS, University of Barcelona, Barcelona. Spain
Ángela Trueba-Vicente
3Department of Internal Medicine. Hospital de Emergencias Enfermera Isabel Zendal. Madrid. Spain
Ana Urbelz-Pérez
3Department of Internal Medicine. Hospital de Emergencias Enfermera Isabel Zendal. Madrid. Spain
Vicente Gómez-Del Olmo
4Department of Internal Medicine. Hospital Universitario Ramón y Cajal. Madrid. Spain
Pablo Demelo-Rodriguez
5Department of Internal Medicine. Hospital General Universitario Gregorio Marañón. Madrid. Spain
Alberto Rivera-Gallego
6Department of Internal Medicine. Hospital Álvaro Cunqueiro. Vigo, Pontevedra. Spain
Pau Bosch-Nicolau
7Department of Infectious Diseases. Hospital Universitario Vall d’Hebron. Barcelona. Spain
Montserrat Perez-Pinar
8Department of Internal Medicine. Hospital Virgen de la Luz. Cuenca. Spain
Mónica Rios-Prego
9Department of Internal Medicine. Complexo Hospitalario Universitario de Pontevedra. Pontevedra. Spain
Olga Madridano-Cobo
10Department of Internal Medicine. Hospital Universitario Infanta Sofía. San Sebastián de los Reyes, Madrid. Spain
Laura Ramos-Alonso
11Department of Internal Medicine. Hospital Universitario A Coruña. A Coruña. Spain
Jesús Alonso-Carrillo
12Department of Internal Medicine. Hospital Universitario 12 de Octubre. Madrid. Spain
Iria Francisco-Albelsa
13Department of Internal Medicine. Hospital Universitari de Girona Dr. Josep Trueta. Girona. Spain
Edelmira Martí-Saez
14Department of Haematology. Hospital Clínico Universitario de Valencia. Valencia. Spain
Ana Maestre-Peiró
15Department of Internal Medicine. Hospital Universitario de Vinalopó. Elche, Alicante. Spain
Manuel Méndez-Bailón
16Department of Internal Medicine. Hospital Clinico San Carlos.UniversidadComplutense,Madrid.Spain
José Ángel Hernández-Rivas
17Department of Hematology. Hospital Universitario Infanta Leonor. Universidad Complutense. Madrid. Spain
Juan Torres-Macho
18Department of Internal Medicine. Hospital Universitario Infanta Leonor. Madrid. Spain
Data Availability
All relevant data are within the manuscript and its Supporting Information files. The data underlying the results presented in the study are available from https://prothromcovid.org/
Posted May 05, 2022.
Optimal thromboprophylaxis strategies in non-critically ill patients with COVID-19 pneumonia. The PROTHROMCOVID Randomized Controlled Trial
Nuria Muñoz-Rivas, Jesús Aibar, Cristina Gabara-Xancó, Ángela Trueba-Vicente, Ana Urbelz-Pérez, Vicente Gómez-Del Olmo, Pablo Demelo-Rodriguez, Alberto Rivera-Gallego, Pau Bosch-Nicolau, Montserrat Perez-Pinar, Mónica Rios-Prego, Olga Madridano-Cobo, Laura Ramos-Alonso, Jesús Alonso-Carrillo, Iria Francisco-Albelsa, Edelmira Martí-Saez, Ana Maestre-Peiró, Manuel Méndez-Bailón, José Ángel Hernández-Rivas, Juan Torres-Macho, The PROTHROMCOVID Trial investigators
medRxiv 2022.05.03.22274594; doi: https://doi.org/10.1101/2022.05.03.22274594
Optimal thromboprophylaxis strategies in non-critically ill patients with COVID-19 pneumonia. The PROTHROMCOVID Randomized Controlled Trial
Nuria Muñoz-Rivas, Jesús Aibar, Cristina Gabara-Xancó, Ángela Trueba-Vicente, Ana Urbelz-Pérez, Vicente Gómez-Del Olmo, Pablo Demelo-Rodriguez, Alberto Rivera-Gallego, Pau Bosch-Nicolau, Montserrat Perez-Pinar, Mónica Rios-Prego, Olga Madridano-Cobo, Laura Ramos-Alonso, Jesús Alonso-Carrillo, Iria Francisco-Albelsa, Edelmira Martí-Saez, Ana Maestre-Peiró, Manuel Méndez-Bailón, José Ángel Hernández-Rivas, Juan Torres-Macho, The PROTHROMCOVID Trial investigators
medRxiv 2022.05.03.22274594; doi: https://doi.org/10.1101/2022.05.03.22274594
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2154)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)